PLRX PLIANT THERAPEUTICS, INC.
Nasdaq · SEC CIK 1746473 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $163.6K 4 sales by 4 insiders
- Filings on record
- 150 since 2021-07-01, latest 2026-07-13 16:32
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Coulie Bernard | Pres, CEO, Dir | — | $114.4K |
| Cummings Keith Lamont | CFO | — | $30.7K |
| Cheung Lily | Chief Human Resource Off | — | $9,644 |
| Kuo Minnie | COO | — | $8,854 |
Transactions 108
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-27 | 2022-10-25 | PLRX | Lefebvre Eric | Chief Medical Off | S - Sale | $25.05 | -5,000 | 133.4K | -4% | -$125.2K | |
| 2022-09-22 | 2022-09-20 | PLRX | Third Rock Ventures III, L.P. | 10% | J - Other | — | -2.00M | 3.84M | -34% | — | |
| D | 2022-09-14 | 2022-09-12 | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $22.54 | -12.5K | 59.3K | -17% | -$281.8K |
| D | 2022-09-14 | 2022-09-12 | PLRX | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $2.08 | +12.5K | 71.8K | +21% | +$26.0K |
| 2022-07-13 | 2022-07-11 | PLRX | Lefebvre Eric | Chief Medical Off | S - Sale | $20.00 | -3,000 | 138.4K | -2% | -$60.0K | |
| DM | 2022-07-13 | 2022-07-11+ | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $22.50 | -27.5K | 59.3K | -32% | -$618.7K |
| DM | 2022-07-13 | 2022-07-11+ | PLRX | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $2.08 | +27.5K | 74.3K | +59% | +$57.2K |
| D | 2021-09-03 | 2021-09-03 | PLRX | Cummings Keith Lamont | CFO | M - OptEx | $2.08 | +20.0K | 67.6K | +42% | +$41.6K |
Purchase Sale Sale after option exercise All abbreviations